Form 4: Abbott Laboratories Director Michelle Kumbier Reports Changes in Beneficial Ownership

Director Michelle Kumbier reports acquisition of restricted stock units and disposal of common shares of Abbott Laboratories.

Summary

• On April 26, 2024, Michelle Kumbier, a director of Abbott Laboratories, reported changes in beneficial ownership.
• Kumbier acquired 1,866 common shares without par value as restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program.
• These restricted stock units will be paid in Abbott common shares on a one-to-one basis upon separation from service, death, or a change in control.
• Kumbier also disposed of 14,079 common shares.
• Following these transactions, the total number of common shares beneficially owned by Kumbier is not explicitly stated, but can be calculated from the document.

Sentiment

Score: 5

Explanation: This is a standard regulatory filing related to stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in Abbott common shares upon the occurrence of certain events, such as separation from service, death, or a change in control, as defined in the Abbott Laboratories 2017 Incentive Stock Program.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common for directors and officers of publicly traded companies. It provides transparency to investors regarding the trading activities of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps stakeholders understand the actions of company directors related to their holdings in the company.

Key Dates